Bob A. Rappaport

Dr. Rappaport has 20 years’ experience at the Food and Drug Administration, with the last 12 years as Director of the Anesthesia, Analgesia, and Addiction Products Division at the Center for Drug Evaluation and Research. There he led a large team of physicians, scientists and project managers in the Division that’s expected to review Bridge’s drug candidates. In 2014, he Received the FDA’s Lifetime Achievement Award.

Dr. Rappaport graduated from and completed his medical training at The George Washington University School of Medicine and Health Sciences. He is board certified in neurology and sleep medicine. He is the recipient of numerous awards and has established research initiatives at the FDA in the areas of anesthesia, analgesia, and addiction.